Tech Mahindra expects to begin trials for planned Covid-19 drug in 3-4 months1 min read . Updated: 10 Aug 2021, 05:50 PM IST
Tech Mahindra along with Reagene Biosciences has filed for patent for a molecule that can be used to develop a drug against Covid-19
NEW DELHI : Tech Mahindra expects to start trials for a Covid drug in the next three to four months after receiving the patent for a particular molecule, according to a senior official.
Select your Category